CIK 0000879169 · Large accelerated filer
INCYTE CORP
Sign in to watch- Ticker
- INCY
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943136539
- Phone
- 3024986700
- Business address
- 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
- Former names
- INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,435,748
- in 1 filing, $28.4M under 10b5-1 plans
Net −$28,435,748. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Sale 10b5-1 | −48,576 | $119.66 | $5.8M | 30,916 |
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −8,539 | 1 | ||
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −12,335 | 0 | ||
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −16,428 | 0 | ||
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −15,054 | 0 | ||
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −23,526 | 2,139 | ||
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −18,331 | 10,054 | ||
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −19,749 | 10,831 | ||
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −12,305 | 18,783 | ||
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −6,907 | 20,722 | ||
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −16,428 | 0 | ||
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −12,743 | 0 | ||
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −15,054 | 0 | ||
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −24,838 | 2,258 | ||
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise · Incentive Stock Option (right to buy) 10b5-1 | −879 | 0 | ||
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −17,986 | 0 | ||
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −19,091 | 0 |
Page 2 of 2 · 37 trades